Are you a neurodivergent or neurodivergent-affirming licensed clinician (counselor, therapist, psychologist, social worker) interested in:
- participating in the Phase III Clinical Trial of the WRADIANCE© instrument and protocol;
- using it in your practice; and
- contributing to the final round of data collection and analysis of this new approach to assessing autism in women?
If so, we would love to hear from you and are accepting applications of interest. We anticipate Phase III will begin in early-to-mid 2026.
Your message has been sent
Hello, thank you for your inquiry. It has been recorded and your name and contact information has been placed on our list.